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In multiple sclerosis, there is increasing evidence that demyelination, and neuronal damage occurs preferentially in cortical grey
matter next to the outer surface of the brain. It has been suggested that this may be due to the effects of pathology outside the
brain parenchyma, in particular meningeal inﬂammation or through cerebrospinal ﬂuid mediated factors. White matter lesions are
often located adjacent to the ventricles of the brain, suggesting the possibility of a similar outside-in pathogenesis, but an inves-
tigation of the relationship of periventricular normal-appearing white matter abnormalities with distance from the ventricles has
not previously been undertaken. The present study investigates this relationship in vivo using quantitative magnetic resonance
imaging and compares the abnormalities between secondary progressive and relapsing remitting multiple sclerosis. Forty-three
patients with relapsing remitting and 28 with secondary progressive multiple sclerosis, and 38 healthy control subjects were
included in this study. T1-weighted volumetric, magnetization transfer and proton density/T2-weighted scans were acquired for
all subjects. From the magnetization transfer data, magnetization transfer ratio maps were prepared. White matter tissue masks
were derived from SPM8 segmentations of the T1-weighted images. Normal-appearing white matter masks were generated by
subtracting white matter lesions identiﬁed on the proton density/T2 scan, and a two-voxel perilesional ring, from the SPM8 derived
white matter masks. White matter was divided in concentric bands, each 1-mm thick, radiating from the ventricles toward the
cortex. The ﬁrst periventricular band was excluded from analysis to mitigate partial volume effects, and normal-appearing white
matter and lesion magnetization transfer ratio values were then computed for the 10 bands nearest to the ventricles. Compared
with controls, magnetization transfer ratio in the normal-appearing white matter bands was signiﬁcantly lower in patients with
multiple sclerosis. In controls, magnetization transfer ratio was highest in the band adjacent to the ventricles and declined with
increasing distance from the ventricles. In the multiple sclerosis groups, relative to controls, reductions in magnetization transfer
ratio were greater in the secondary progressive multiple sclerosis compared with relapsing remitting multiple sclerosis group, and
these reductions were greatest next to the ventricles and became smaller with distance from them. White matter lesion magnet-
ization transfer ratio reductions were also more apparent adjacent to the ventricle and decreased with distance from the ventricles
in both the relapsing remitting and secondary progressive multiple sclerosis groups. These ﬁndings suggest that in people with
multiple sclerosis, and more so in secondary progressive than relapsing remitting multiple sclerosis, tissue structural abnormalities
in normal-appearing white matter and white matter lesions are greatest near the ventricles. This would be consistent with a
cerebrospinal ﬂuid or ependymal mediated pathogenesis.
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Introduction
The pathogenesis of progressive multiple sclerosis remains
unknown, but recent studies have raised the possibility of
factors external to the brain parenchyma playing a signiﬁ-
cant role. In people with secondary progressive multiple
sclerosis (SPMS), grey matter lesions may be as or more
extensive than white matter lesions, (Bø et al., 2003;
Lassmann, 2014), and grey matter lesions are much more
abundant in the outer (subpial) cortical layers when com-
pared with the cortex next to white matter (Bø et al.,
2003). Similarly, neuronal loss in multiple sclerosis may
be substantial in the cortex (Wegner et al., 2006), and is
also greatest in the outer (subpial) compared with inner
cortical layers (Magliozzi et al., 2010). This gradient in
cortical grey matter lesions and neuronal pathology has
been linked with meningeal inﬂammation, in particular
the presence of B cell follicle-like aggregates in SPMS
(Magliozzi et al., 2007, 2010), and it has been suggested
that meningeal inﬂammation or CSF-mediated factors may
play a key pathogenic role in cortical pathology
White matter lesions occur more frequently around the
ventricle than elsewhere, and a clear explanation for this
distribution has not been found (Narayanan et al., 1997).
They seem to form around veins, and in the case of peri-
ventricular lesions around subependymal veins (Adams
et al., 1987), but the mechanism for this has not been
determined. Perivascular (venous) inﬂammatory inﬁltrates
are seen in multiple sclerosis lesions (Adams, 1975), but
it is not known if they are necessary for lesion genesis or
part of a more chronic process. Tissue hypoxia has been
suggested as having a pathogenic role in lesion formation
(Lassmann, 2003), and for haemodynamic reasons
periventricular white matter may be more likely than
other parts of the brain to become hypoxic, explaining
the predilection for lesion formation in this region (Beggs,
2013). Patchy ‘granular ependymitis’ has also been
observed in a single study by Adams et al. (1987), although
only co-localized with 1 in 10 periventricular lesions.
In light of ﬁndings in cortical grey matter, which suggest
a possible outside-in pathogenesis, it would be of interest to
know if the characteristics of normal-appearing white
matter (NAWM) were also dependent on their location
relative to the ventricular CSF interface. However, there
is a paucity of histopathological or MRI studies that have
looked for such an association in periventricular NAWM.
One histopathological study looked at white matter lesion
features dependent on their distance from the ventricles,
speciﬁcally looking at glial progenitor cell density, and
found that it was highest in the lesions in the subventricular
(subependymal) zone (Nait-Ousmesmar et al. 2007). One
MRI study looked at white matter lesion features depend-
ent on their distance from the ventricles, which found
that lesions are more likely to be hypointense on
T-weighted images the closer they are to the ventricles
(Papadopoulou et al., 2014).
Magnetization transfer ratio (MTR) is a MRI technique
that has proven sensitive to multiple sclerosis pathology in
white matter lesions and NAWM (Horsﬁeld, 2005). In
combined MRI and histopathological studies, reductions
in MTR have been found to correlate with both demyelin-
ation and axonal loss, and as such it is sensitive to two
major elements of white matter pathology in multiple scler-
osis (Schmierer et al., 2004). With recent technical ad-
vances, it is now possible to obtain MTR maps at 1-mm
isotropic resolutions, and this has allowed us to subdivide
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the cortex into inner and outer bands. We found a prefer-
ential multiple sclerosis disease effect on the outer (subpial)
relative to the inner cortex in people with SPMS (Samson
et al., 2014).
In this study, using the same high resolution MTR
method, we aimed to investigate two questions: (i) in
people with relapsing-remitting multiple sclerosis (RRMS)
and SPMS, is there a relationship between NAWM and
white matter lesion MTR, and distance from the ventricles?
And (ii) are periventricular NAWM and lesion MTR
abnormalities more prominent in SPMS compared with
RRMS?
Materials and methods
Subjects
Participants were between 18 and 65 years old. Those
with multiple sclerosis had to have a diagnosis of clinically
deﬁnitive multiple sclerosis according to McDonald criteria
(Polman et al., 2005), and multiple sclerosis subtypes were
classiﬁed using the Lublin-Reingold (Lublin et al., 1996) cri-
teria. The control group had to have no known neurological
disease. All participants provided written informed consent.
This study was approved by our local institutional ethics
committee.
We included 71 people with multiple sclerosis: 43 with
RRMS and 28 with SPMS. The mean  standard deviation
(SD) ages were 42.5  10.0 and 53.0  8.1, respectively, and
disease duration from ﬁrst symptom onset was 11.7  8.1and
21.9  10.4. Forty-eight (68%) were female. The median
Expanded Disability Status Scale (Kurtzke, 1983) was 5.5
(range 1–8.5). Thirty-ﬁve (49%) of the multiple sclerosis
group were receiving a disease-modifying treatment at time
of the study. Thirty-eight people served as controls, mean
(SD) age 39.1  11.9, 21 (55%) females.
MRI
Using a 3T Philips Achieva system (Philips Healthcare) with a
32-channel head coil and multi-transmit technology, the fol-
lowing sequences were acquired: 3D sagittal T1-weighted fast
ﬁeld echo (FFE) scan: 1  1  1mm3, inversion time = 824ms,
repetition time = 6.9ms, echo time = 3.1ms; dual-echo proton
density/T2-weighted axial-oblique scans aligned with the anter-
ior to posterior commissure line (1  1  3mm3, repetition
time = 3500ms, echo time = 19/85ms); and high resolution
magnetization transfer imaging using a 3D slab-selective
FFE sequence with two echoes (1  1  1mm3, repetition
time = 6.4ms, echo time = 2.7/4.3ms, alpha = 9 with and
without sinc Gaussian-shaped magnetization transfer pulses
of nominal alpha = 360, offset frequency 1 kHz, duration
16ms. A turbo ﬁeld echo (TFE) readout was used, with
an echo train length of four, TFE shot interval 32.5ms,
giving a total time between successive magnetization transfer
pulses of 50ms, and scan time 25min). The two echoes were
averaged (thereby increasing the signal-to-noise ratio) for both
the magnetization transfer on and -off data used to calculate
the MTR.
Image analysis
Segmentation of T1-weighted 3D images
The T1-weighted scans were segmented using Statistical
Parametric Mapping (SPM8; Wellcome Trust Centre for
Neuroimaging, London, UK; www.ﬁl.ion.ucl.ac.uk/; using the
new segment pipeline) after white matter lesion ﬁlling (Chard
et al. 2010), and the resultant grey matter, white matter and
CSF probability maps were then binarized. To minimize the
potential for partial volume effects between tissues, the prob-
ability of each voxel being of a given tissue type had to be
590% (Samson et al., 2014). In addition, brain parenchymal
fraction (grey matter and white matter tissue volume divided
by grey matter, white matter plus CSF volume) was measured
using the same SPM8 tissue segmentations, for use as a cov-
ariate in the statistical models.
Extraction of normal-appearing white matter
White matter lesions were identiﬁed and contoured on proton
density/T2 scans using JIM (Version 6.0, Xinapse Systems). For
each participant the white matter lesion masks from the proton
density/T2 images were then co-registered to the corresponding
T1-weighted 3D scan. To achieve this, a pseudo-T1 image was
generated by subtracting the proton density from the
T2-weighted image (Hickman et al., 2002), so providing an
image with a similar contrast to the T1-weighted 3D scan.
Using NiftyReg (Ourselin et al., 2001; Modat et al., 2010), a
linear transformation was then computed to co-register the
pseudo-T1 image to the T1-weighted 3D image, and then the
same transformation was applied to the proton density/T2
lesion mask. A previous study has shown that MTR is signiﬁ-
cantly more abnormal in the white matter 1–2mm adjacent to
the edge of a multiple sclerosis lesion, as seen on a proton
density/T2-weighted scan, when compared with white matter
more distant from the lesion margin (Vrenken et al., 2006). To
prevent this from affecting NAWM MTR measurements in this
study, a perilesional tissue mask was prepared by dilating the
proton density/T2 lesion mask 2mm in each direction.
Binarized white matter lesions and perilesional tissue masks
were then subtracted from each subject’s binarized white
matter mask to create a NAWM mask. As further precaution
against lesion contamination of NAWM, the same analysis
was rerun using a three voxels dilation of white matter
lesion masks. The results of this analysis are reported in the
Supplementary material.
Co-registration of magnetization transfer data to
T1-weighted images
Magnetizationon (MTon) and magnetizationoff (MToff) images
for each subject were afﬁne registered to T1-weighted volume
image using NiftyReg, and MTR maps calculated
[MTR = (MToff  MTon) / MToff], measured in percentage
units (pu).
Segmentation of white matter into concentric
periventricular one-voxel thick bands
For each subject NAWM was segmented into concentric one-
voxel thick bands starting at the ventricular margin and ex-
tending in to the brain parenchyma (Fig. 1). To prevent
NAWM bands arising simultaneously from the body and tem-
poral horns of the lateral ventricles from clashing, only white
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matter and ventricular CSF superior to the insula were
included in the analysis (Fig. 1).
For each subject, a mask of the body of the lateral ventricles
was ﬁrst created by linearly co-registering their thresholded
CSF map with the lateral ventricle mask included in the
Wake Forest University School of Medicine PickAtlas toolbox
(Maldjian et al., 2003). This mask was reviewed and if
required manually edited (by Z.L.) to ensure a robust match
with lateral ventricle anatomy in each subject. The CSF mask
was then repeatedly dilated by one voxel (1  1  1mm3)
using DilM (part of the FSL software package (http://www.
fmrib.ox.ac.uk/fsl/) through NAWM to generate concentric
one-voxel thick NAWM bands. In each subject, sequential
bands were extracted until the volume of any given band fell
below 0.5ml. This yielded a series of NAWM bands extending
from the ventricles through to the cortex. As an extra precau-
tion against periventricular CSF-white matter partial volume
effects, data from the ﬁrst band was not included in subse-
quent analyses. As the aim of this study was to look for peri-
ventricular multiple sclerosis disease effects, MTR values were
extracted for the ﬁrst 10 NAWM bands (i.e. covering 1 cm of
distance between the ventricles and cortex).
White matter lesion measures
To calculate white matter lesion volumes and MTR values
dependent on their distance from the ventricles, a similar pro-
cedure to that used to obtain NAWM data was used.
Ventricular CSF was sequentially dilated by 1 voxel (as
above) through the white matter lesion mask, so generating
a set of concentric white matter lesion masks. Mean and SD
white matter lesion MTR and volumes were then calculated.
Statistical analyses
Demographic data and MTR values are presented as
mean  SD. Expanded Disability Status Scale values are pre-
sented as median (range). Statistical analyses were computed
using SPSS (version 22, IBM). In each subject, MTR values
within each NAWM band were averaged. The average MTR
in each NAWM band was then separately compared between
groups using general linear models, including age and gender
as potentially confounding factors. Rather than run different
models for each possible pairwise combination of groups, all
three study groups (healthy controls, RRMS and SPMS) were
included in a single model for each NAWM band, so allowing
group differences to be tested simultaneously. As a further
precaution against CSF partial volume effects, and to allow
for potential differences in the relative alignment of NAWM
bands due to disease associated atrophy, both the total number
of NAWM bands extracted and brain parenchymal fraction
were included as additional covariates. Gradients in NAWM
MTR were calculated between pairs of bands and divided by
the number of intervals spanned (e.g. the MTR gradient be-
tween bands 1 and 5 was calculated by subtracting the mean
MTR value in band 5 from that in band 1, and dividing by 4).
P4 0.05 was considered to be the threshold for statistical
signiﬁcance.
Results
Participant demographics, clinical characteristics, and MTR
values are given in Table 1. Figure 2 shows the mean
(standard error) NAWM MTR in each group. Figure 3A
shows the corresponding white matter lesion MTR values
and Fig. 3B the white matter lesion volumes.
From Fig. 2 it can be seen that in healthy controls, the
NAWM MTR was highest in the immediate periventricular
NAWM band, and then declined with distance from the
ventricles. In people with multiple sclerosis, NAWM
MTR was lower than that in controls (Table 2). The mul-
tiple sclerosis-associated reduction in MTR was greatest in
the NAWM adjacent to the ventricles, and noticeably
declined with increasing distance from the ventricles until
band 5. Whereas in controls MTR was higher in band 1
than band 5, in multiple sclerosis MTR was higher in band
5 than band 1. We therefore tested between group differ-
ences in NAWM MTR in bands 1, 5 and (for reference) 10,
and MTR gradients between bands 1 and 5, and 5 and 10.
Compared with controls MTR was signiﬁcantly lower in
bands 1, 5 and 10 in overall multiple sclerosis groups, as
well as in RRMS and SPMS subgroups (Table 2). In band 1
MTR was signiﬁcantly lower in the SPMS compared with
RRMS group (Table 2). Age effects were not signiﬁcant.
Figure 1 NAWM above the superior limit of the insula was segmented into concentric periventricular one-voxel thick bands.
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Gender had a signiﬁcant effect in band 5 and 10; however,
this did not materially alter the observed inter-group differ-
ences and so unadjusted results are presented (Table 2).
Covarying for brain parenchymal fraction or for the
number of bands extracted did not materially alter the re-
sults, except for the comparison of MTR in band 1 be-
tween RRMS and SPMS groups, which reduced the
statistical signiﬁcance of differences between them to a bor-
derline level (Supplementary Table 1). Compared with con-
trols, MTR gradients between bands 1 and 5 differed
signiﬁcantly with both the multiple sclerosis subgroups or
overall multiple sclerosis groups (Table 3). Between bands
5 and 10, changes in MTR differed signiﬁcantly between
the control and the multiple sclerosis groups (Table 3).
Comparing the multiple sclerosis subgroups, NAWM
MTR gradients between bands 1 and 5 were signiﬁcantly
greater in the SPMS compared with RRMS group. Age and
gender were not signiﬁcant in these models, and covarying
for the total number of bands or brain parenchymal
fraction did not materially affect them (Supplementary
Table 2), and so unadjusted results are presented.
Lesion MTR and volume by distance from the ventricles
is shown in Fig. 3A and B. It can be seen that with distance
from the ventricles lesion volume decreases, and from
bands 1 to 5 lesion MTR increases. Beyond band 5, lesions
volumes are very small, and lesion MTR measures becomes
more variable, but as with NAWM, they appear to plateau
and then decline, so mirroring (at a lower level) the MTR
gradient between bands seen in control white matter.
Dilating the white matter lesion masks by three voxels
did not materially alter the results (Supplementary Tables
3 and 4 and Supplementary Fig. 1).
Discussion
In the multiple sclerosis groups MTR was reduced through-
out the NAWM; however, the distribution of MTR values
did not simply mirror, at a lower level, those in healthy
controls. Instead, there was a clearly greater multiple scler-
osis disease effect close to the ventricles. Similar ﬁndings
were noted in white matter lesions, with the magnitude of
MTR reductions within lesion decreasing with distance
from the ventricles. These ﬁndings strongly indicate that
not only are lesions more likely to occur around the ven-
tricles (Narayanan et al., 1997) (Fig. 3B), but pathological
changes within NAWM and white matter lesions are also
greater around the ventricles (Figs 2 and 3A). This suggests
that pathology in white matter occurs preferentially at or
near the inner surface of the brain.
Considering technical factors that may have inﬂuenced
these results, inclusion of ventricular CSF in the NAWM
and white matter lesions masks could spuriously reduce
periventricular MTR. However, we think this is highly un-
likely for four reasons. First, we used a stringent threshold
(90%) to binarize the SPM8 tissue segmentations. Second,
we discarded MTR data in the ﬁrst NAWM and white
matter lesion bands in each subject. Third, covarying for
the total number of NAWM bands or brain parenchymal
fraction (a measure of brain atrophy) in the statistical ana-
lyses did not materially alter the results. Fourth, there was
no periventicular reduction in MTR seen in controls, and
we would expect to see at least a hint of this if partial
Table 1 Participant characteristics
Healthy controls RRMS SPMS
n 38 43 28
Mean age, years  SD (range) 39.1  11.9 (23–63) 42.5  10.0 (25–64) 53.0  8.1 (36–65)
Gender male/female 17/21 14/29 9/19
Median EDSS (range) NA 2 (1.0-7.0) 6.5 (4.0–8.5)
Disease duration, years  SD NA 11.7  8.1 21.9  10.4
Mean MTR in whole NAWM  SD 39.7  0.8 38.9  1.5 38.4  1.9
Mean number of bands extracted  SD 44.0  3.2 42.7  3.2 41.1  3.8
Mean brain parenchymal fraction  SD 0.82  0.02 0.80  0.02 0.80  0.03
EDSS = Expanded Disability Status Scale; NA = not available.
Figure 2 NAWM band MTR in each subgroup. Mean  2 
standard error. MTR is given in per cent units (pu).
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volume with CSF was signiﬁcantly affecting periventricular
NAWM MTR measures.
It is also highly unlikely that there was any lesion con-
tamination of NAWM (that would reduce NAWM MTR).
First, based on work by Vrenken et al. (2006), who demon-
strated that perilesional reductions in MTR were detectable
for 1 to 2mm, we dilated our lesion masks by two voxels
i.e. the linear equivalent of at least 2mm, making it very
unlikely that any residual lesions or perilesional tissues
could have contributed signiﬁcantly to NAWM measures.
We also re-ran the analysis dilating lesions by three voxels,
and this did not materially alter the results (Supplementary
material). Secondly, the pattern of changes between bands
in NAWM MTR (Fig. 2) and white matter lesion MTR
(Fig. 3A) are similar, and this would be difﬁcult to account
for through consistent partial volume between them.
Further investigation of whether or not periventricular
NAWM MTR abnormalities occur independently of lesions
could be undertaken by studying subjects who do not have
periventricular lesions. We could not investigate this in our
cohort as almost all had periventricular lesions, which is
usually the case in established multiple sclerosis. A future
study of people with clinically isolated syndromes or clin-
ically very early multiple sclerosis—more of whom may not
have periventricular lesions—would be of interest.
Brain atrophy could lead to the relative position of
NAWM bands differing between people, e.g. band 10 in
one person may fall a quarter of the way from the ven-
tricular margin to the cortex, whereas in another person it
may be halfway between them. However, misalignment of
Figure 3 White matter lesion MTR and volumes. (A) White
matter lesion MTR for each band in the RRMS and SPMS groups. (B)
White matter lesion volume for each band in the RRMS and SPMS
groups. Data are mean  2  standard error.
Table 2 Mean MTR values in NAWM bands 1, 5 and 10
from lateral ventricle
Band Type Mean (SE)
MTR (pu)
Differences
1 Healthy controls 41.0 (0.14) HC versus RRMS:
P5 0.001
HC versus SPMS:
P5 0.001
RRMS versus SPMS:
P = 0.019
All multiple
sclerosis
38.9 (0.19)
RRMS 39.2 (0.24)
SPMS 38.4 (0.27)
5 Healthy controls 40.6 (0.13) HC versus RRMS:
P5 0.001
HC versus SPMS:
P5 0.001
RRMS versus SPMS:
P = 0.152
All multiple
sclerosis
39.2 (0.15)
RRMS 39.4 (0.20)
SPMS 39.0 (0.22)
10 Healthy controls 40.3 (0.14) HC versus RRMS:
P5 0.001
HC versus SPMS:
P5 0.001
RRMS versus SPMS:
P = 0.258
All multiple
sclerosis
39.1 (0.14)
RRMS 39.3 (0.18)
SPMS 39.0 (0.21)
HC = healthy controls; pu = per cent units.
Table 3 MTR gradients between NAWM bands 1, 5
and 10
Bands Type Mean (SE)
MTR change
(pu, per
band interval)
Differences
1 to 5 HC 0.11 (0.01) HC versus RRMS:
P5 0.001
All multiple
sclerosis
0.08 (0.03) HC versus SPMS:
P5 0.001
RRMS 0.04 (0.03) RRMS versus SPMS:
P = 0.027
SPMS 0.14 (0.04) HC versus RRMS:
P = 0.007
5 to 10 HC 0.07 (0.01) HC versus SPMS:
P = 0.001
All multiple
sclerosis
0.02 (0.01) RRMS versus SPMS:
P = 0.253
RRMS 0.03 (0.01)
SPMS 0.01 (0.02)
HC = health controls; pu = per cent units.
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NAWM bands due to atrophy could not account for the
MTR gradients seen (as it will tend to ﬂatten gradients
within each group) or differences between groups (as it
will increase variability in group-wide MTR measures
within each band). However, as a further precaution we
also included both the total number of NAWM bands ex-
tracted and brain parenchymal fraction as covariates in the
statistical models, and this did not materially alter the
results.
A gradient in disease-associated MTR reductions was
seen in all multiple sclerosis groups, but the periventricular
reduction was signiﬁcantly greater in the SPMS group when
compared with RRMS. Several possible mechanisms might
contribute to preferential periventricular abnormalities in
multiple sclerosis, although with the currently limited infor-
mation available it is not possible to determine which is the
primary one. First, CSF mediated factors may be relevant.
This could provide a unifying explanation for the predilec-
tion for cortical grey matter pathology to occur next to the
outer surface of the brain (Bø et al., 2003; Magliozzi et al.,
2007, 2010; Samson et al., 2014) and the periventricular
NAWM MTR gradients seen in the present study. CSF
from people with multiple sclerosis has been shown to
induce both oligodendrocyte (Hughes and Field, 1967)
and neuronal damage in cell cultures (Vidaurre et al.,
2014). Secondly, inﬂammatory activity in the ependyma
may be a factor. In a single histopathological study,
Adams et al. (1987) found the ependyma overlying periven-
tricular white matter to be focally abnormal, and inter-
preted this as representing ependymitis. Thirdly, it has
been suggested that periventricular white matter is more
likely than other white matter regions to become hypoxic
when oxygen availability is reduced (Beggs, 2013) although
hypoxia is also only thought to be a signiﬁcant factor in the
pathogenesis of a minority of white matter lesions
(Lucchinetti et al., 2000; Lassmann, 2003).
The differences in the observed MTR gradients between
people with multiple sclerosis and healthy controls are very
difﬁcult to explain on the basis of technical factors, such as
partial volume, alone. However, there are some other limi-
tations to consider. Because of the morphological complex-
ity of dilating the whole ventricular system through white
matter, and the potential for bands arising from the body
of lateral ventricles overlapping with those from the tem-
poral horns, we restricted our analysis to tissues above the
insula. In addition, speciﬁc pathological interpretation of
white matter MTR is difﬁcult as it is sensitive to both de-
myelination and axonal loss (Schmierer et al., 2004),
demyelination and axonal loss are highly correlated
(Schmierer et al., 2004), and so we cannot determine
which is mostly responsible for the gradient seen. In a
recent spinal cord study in people with multiple sclerosis,
a reduction in MTR has also been observed in the outer-
most cord voxel layer and, in addition to demyelination
and axonal loss, the possibility of a direct effect of inﬂam-
matory inﬁltrates was also raised (Kearney et al., 2014).
Quantitative histopathological assessment of the ependyma
and periventricular white matter is warranted to provide
further insight into the cause of the MTR abnormalities
observed in this study.
In conclusion, we have found a gradient in MTR
abnormalities from periventricular through to deep
NAWM in people with multiple sclerosis, with the most
marked abnormality seen in the immediate periventricular
region and in SPMS. In combination with previous obser-
vations about cortical pathology, this suggests that there is
a predilection for pathology to occur near the surface of the
brain, particularly in SPMS. The present results highlight
the need for further work clarifying the potential role of
factors such as CSF mediators, ependymal inﬂammation,
and periventricular tissue hypoxia, in the pathogenesis of
lesional and non-lesional abnormalities in multiple scler-
osis, and of SPMS.
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